Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 238,457 | 125,024 | 63,447 | 66,193 | 174,017 |
| Cost of Goods | 923 | N/A | 8,146 | 9,557 | 15,214 |
| Gross Profit | 237,534 | 125,024 | 55,301 | 56,636 | 158,803 |
| Operating Expenses | 324,706 | 240,397 | 163,102 | 181,614 | 153,371 |
| Operating Income | -86,249 | -115,373 | -107,655 | -124,421 | 5,646 |
| Interest Expense | 7,752 | 12,043 | 12,043 | 12,046 | 12,175 |
| Other Income | 17,223 | 20,897 | 16,548 | 41,021 | 48,228 |
| Pre-tax Income | -76,778 | -106,519 | -103,150 | -95,446 | 41,699 |
| Income Tax | 2,351 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -79,129 | -106,519 | -103,150 | -95,446 | 41,699 |
| Net Income | $-79,129 | $-106,519 | $-102,337 | $-95,446 | $41,699 |
| EPS Basic Total Ops | -1.00 | -1.61 | -1.77 | -1.71 | 0.75 |
| EPS Basic Continuous Ops | -1.00 | -1.61 | -1.78 | -1.71 | 0.75 |
| EPS Diluted Total Ops | -1.00 | -1.61 | -1.77 | -1.71 | 0.74 |
| EPS Diluted Continuous Ops | -1.00 | -1.61 | -1.78 | -1.71 | 0.74 |
| EBITDA(a) | $-74,962 | $-103,886 | $-93,063 | $-108,917 | $21,008 |